UA28103U - Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов - Google Patents

Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов Download PDF

Info

Publication number
UA28103U
UA28103U UAU200707897U UAU200707897U UA28103U UA 28103 U UA28103 U UA 28103U UA U200707897 U UAU200707897 U UA U200707897U UA U200707897 U UAU200707897 U UA U200707897U UA 28103 U UA28103 U UA 28103U
Authority
UA
Ukraine
Prior art keywords
wounds
drug
aerosil
effect
trophic ulcers
Prior art date
Application number
UAU200707897U
Other languages
English (en)
Ukrainian (uk)
Inventor
Ольга Олександрівна Біляєва
Олександр Андрійович Голуб
Вячеслав Васильович Нешта
Original Assignee
Ольга Олександрівна Біляєва
Олександр Андрійович Голуб
Вячеслав Васильович Нешта
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ольга Олександрівна Біляєва, Олександр Андрійович Голуб, Вячеслав Васильович Нешта filed Critical Ольга Олександрівна Біляєва
Priority to UAU200707897U priority Critical patent/UA28103U/ru
Publication of UA28103U publication Critical patent/UA28103U/ru
Priority to CN200880024342XA priority patent/CN101772356B/zh
Priority to US12/668,827 priority patent/US9302027B2/en
Priority to EP08779534A priority patent/EP2170415B1/en
Priority to EA201070130A priority patent/EA016764B1/ru
Priority to PCT/UA2008/000041 priority patent/WO2009008851A2/en
Priority to MX2010000367A priority patent/MX2010000367A/es
Priority to BRPI0814549-0A priority patent/BRPI0814549B1/pt
Priority to SI200830123T priority patent/SI2170415T1/sl
Priority to AU2008275852A priority patent/AU2008275852B2/en
Priority to KR1020107003161A priority patent/KR101482960B1/ko
Priority to CA2693087A priority patent/CA2693087C/en
Priority to PL08779534T priority patent/PL2170415T3/pl
Priority to JP2010516012A priority patent/JP5464750B2/ja
Priority to AT08779534T priority patent/ATE488255T1/de
Priority to DE602008003584T priority patent/DE602008003584D1/de
Priority to DK08779534.0T priority patent/DK2170415T3/da
Priority to EP10191280A priority patent/EP2277559A1/en
Priority to MYPI2010000038A priority patent/MY148077A/en
Priority to ES08779534T priority patent/ES2353683T3/es
Priority to PT08779534T priority patent/PT2170415E/pt
Priority to ZA2010/00126A priority patent/ZA201000126B/en
Priority to CY20111100153T priority patent/CY1111652T1/el
Priority to HR20110107T priority patent/HRP20110107T1/hr
Priority to US14/753,641 priority patent/US9757436B2/en
Priority to US15/086,724 priority patent/US20160206709A1/en
Priority to US15/681,407 priority patent/US10166275B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254Enzymes, proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/2404Serralysin (3.4.24.40)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Composite Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Комплексный противобактериальный сорбционный препарат с некролитическим действием для лечения гнойных ран, трофических язв и ожогов, инфильтратов с выраженным некротическим и экссудативным компонентами представляет собой кремнеземный сорбент с иммобилизованным на нем лекарственным средством. В качестве кремнеземного сорбент препарат содержит аэросил, а в качестве лекарственного средства – сератиопептидазу.  
UAU200707897U 2007-07-12 2007-07-12 Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов UA28103U (ru)

Priority Applications (27)

Application Number Priority Date Filing Date Title
UAU200707897U UA28103U (ru) 2007-07-12 2007-07-12 Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов
PT08779534T PT2170415E (pt) 2007-07-12 2008-07-11 Composição antimicrobiana
PL08779534T PL2170415T3 (pl) 2007-07-12 2008-07-11 Kompozycja przeciwbakteryjna
AT08779534T ATE488255T1 (de) 2007-07-12 2008-07-11 Antimikrobielle zusammensetzung
EP08779534A EP2170415B1 (en) 2007-07-12 2008-07-11 Antimicrobial composition
EA201070130A EA016764B1 (ru) 2007-07-12 2008-07-11 Противомикробная композиция
PCT/UA2008/000041 WO2009008851A2 (en) 2007-07-12 2008-07-11 Antimicrobial composition
MX2010000367A MX2010000367A (es) 2007-07-12 2008-07-11 Composicion antimicrobiana.
BRPI0814549-0A BRPI0814549B1 (pt) 2007-07-12 2008-07-11 Composição antimicrobiana
SI200830123T SI2170415T1 (sl) 2007-07-12 2008-07-11 Antimikrobni sestavek
AU2008275852A AU2008275852B2 (en) 2007-07-12 2008-07-11 Antimicrobial composition
KR1020107003161A KR101482960B1 (ko) 2007-07-12 2008-07-11 항균 조성물
CA2693087A CA2693087C (en) 2007-07-12 2008-07-11 Antimicrobial composition
CN200880024342XA CN101772356B (zh) 2007-07-12 2008-07-11 抗菌组合物
JP2010516012A JP5464750B2 (ja) 2007-07-12 2008-07-11 抗菌性組成物
US12/668,827 US9302027B2 (en) 2007-07-12 2008-07-11 Antimicrobial composition comprising pyrogenic silica and serratiopeptidase
DE602008003584T DE602008003584D1 (de) 2007-07-12 2008-07-11 Antimikrobielle zusammensetzung
DK08779534.0T DK2170415T3 (da) 2007-07-12 2008-07-11 Antimikrobielt præparat
EP10191280A EP2277559A1 (en) 2007-07-12 2008-07-11 Antimicrobial composition
MYPI2010000038A MY148077A (en) 2007-07-12 2008-07-11 Antimicrobial composition
ES08779534T ES2353683T3 (es) 2007-07-12 2008-07-11 Composición antimicrobiana.
ZA2010/00126A ZA201000126B (en) 2007-07-12 2010-01-07 Antimicrobial composition
CY20111100153T CY1111652T1 (el) 2007-07-12 2011-02-09 Αντιμικροβiακη συνθεση
HR20110107T HRP20110107T1 (hr) 2007-07-12 2011-02-15 Antimikrobni sastav
US14/753,641 US9757436B2 (en) 2007-07-12 2015-06-29 Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof
US15/086,724 US20160206709A1 (en) 2007-07-12 2016-03-31 Antimicrobial composition comprising pyrogenic silica and serrathopeptidase and uses thereof
US15/681,407 US10166275B2 (en) 2007-07-12 2017-08-20 Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200707897U UA28103U (ru) 2007-07-12 2007-07-12 Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов

Publications (1)

Publication Number Publication Date
UA28103U true UA28103U (ru) 2007-11-26

Family

ID=55588706

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200707897U UA28103U (ru) 2007-07-12 2007-07-12 Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов

Country Status (23)

Country Link
US (4) US9302027B2 (ru)
EP (2) EP2277559A1 (ru)
JP (1) JP5464750B2 (ru)
KR (1) KR101482960B1 (ru)
CN (1) CN101772356B (ru)
AT (1) ATE488255T1 (ru)
AU (1) AU2008275852B2 (ru)
BR (1) BRPI0814549B1 (ru)
CA (1) CA2693087C (ru)
CY (1) CY1111652T1 (ru)
DE (1) DE602008003584D1 (ru)
DK (1) DK2170415T3 (ru)
EA (1) EA016764B1 (ru)
ES (1) ES2353683T3 (ru)
HR (1) HRP20110107T1 (ru)
MX (1) MX2010000367A (ru)
MY (1) MY148077A (ru)
PL (1) PL2170415T3 (ru)
PT (1) PT2170415E (ru)
SI (1) SI2170415T1 (ru)
UA (1) UA28103U (ru)
WO (1) WO2009008851A2 (ru)
ZA (1) ZA201000126B (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079209A3 (en) * 2009-01-08 2010-09-02 Golub Alexandr A Compositions for treating wounds and skin conditions
MD4197C1 (ru) * 2012-10-22 2013-09-30 Мария ДАНУ Метод лечения трофических язв

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102961336B (zh) * 2012-12-13 2014-08-13 清华大学深圳研究生院 纳米级铂类药物及其制备方法
WO2016071405A2 (en) * 2014-11-04 2016-05-12 Invenres Gmbh Pharmaceutical preparation and method of its production and use
US10226425B2 (en) * 2013-11-06 2019-03-12 Invenres Gmbh Pharmaceutical preparation and method of its production and use
CN106558599B (zh) * 2015-09-29 2020-04-07 中芯国际集成电路制造(上海)有限公司 电阻随机存取存储器及其形成方法
CN108309941B (zh) * 2018-03-20 2023-08-11 南京工业大学 一种舍雷肽酶外用粉剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792160A (en) 1972-01-18 1974-02-12 Takeda Chemical Industries Ltd Method of treating inflammation and composition therefor
JPS5826822A (ja) * 1981-08-10 1983-02-17 Kaken Pharmaceut Co Ltd 慢性腎炎治療剤
NZ529957A (en) 2001-07-24 2005-11-25 Advanced Biotechnologies Topical pharmaceutical formulation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079209A3 (en) * 2009-01-08 2010-09-02 Golub Alexandr A Compositions for treating wounds and skin conditions
MD4197C1 (ru) * 2012-10-22 2013-09-30 Мария ДАНУ Метод лечения трофических язв

Also Published As

Publication number Publication date
US20150297787A1 (en) 2015-10-22
US9757436B2 (en) 2017-09-12
MX2010000367A (es) 2010-07-02
MY148077A (en) 2013-02-28
CN101772356B (zh) 2013-05-08
EA201070130A1 (ru) 2010-08-30
HRP20110107T1 (hr) 2011-03-31
US20170368154A1 (en) 2017-12-28
ZA201000126B (en) 2011-04-28
CY1111652T1 (el) 2015-10-07
EA016764B1 (ru) 2012-07-30
JP5464750B2 (ja) 2014-04-09
AU2008275852B2 (en) 2014-02-13
BRPI0814549B1 (pt) 2018-07-03
BRPI0814549A2 (pt) 2017-10-03
US20160206709A1 (en) 2016-07-21
CN101772356A (zh) 2010-07-07
DE602008003584D1 (de) 2010-12-30
PL2170415T3 (pl) 2011-04-29
ES2353683T3 (es) 2011-03-04
CA2693087A1 (en) 2009-01-15
EP2277559A1 (en) 2011-01-26
US9302027B2 (en) 2016-04-05
SI2170415T1 (sl) 2011-02-28
WO2009008851A3 (en) 2009-11-26
US10166275B2 (en) 2019-01-01
PT2170415E (pt) 2011-01-05
AU2008275852A1 (en) 2009-01-15
DK2170415T3 (da) 2010-12-13
WO2009008851A2 (en) 2009-01-15
ATE488255T1 (de) 2010-12-15
KR20100051655A (ko) 2010-05-17
EP2170415B1 (en) 2010-11-17
US20100291062A1 (en) 2010-11-18
EP2170415A2 (en) 2010-04-07
CA2693087C (en) 2016-08-16
JP2010533174A (ja) 2010-10-21
KR101482960B1 (ko) 2015-01-15

Similar Documents

Publication Publication Date Title
US10166275B2 (en) Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof
ES2554259T3 (es) Apósito para heridas con capa permeable al aire
WO2019091150A1 (zh) 一种藻酸盐创面修复敷料及其制备方法
RU2438654C1 (ru) Гидрогелевая композиция для лечения ожогов
CN1850291A (zh) 具有促进伤口愈合、抗菌功能的液体伤口敷料
Udwadia Ghee and honey dressing for infected wounds
RU2471477C1 (ru) Композиция комплекса сукцината хитозана и диоксидина с хлоргексидином, обладающая антибактериальным и ранозаживляющим эффектом
CN101856322B (zh) 一种磺胺嘧啶银控释凝胶及制备方法
Inoue et al. The wound/burn guidelines–1: Wounds in general
Sarheed et al. Honey products and their potential in wound healing
Swaim et al. Management of small animal distal limb injuries
UA28514U (ru) Антисептический перевязочный материал
RU2185149C1 (ru) Ранозаживляющее средство "витамустим-гель" (варианты), способ его приготовления и способ лечения им поврежденой кожи, ран, ожогов и трофических язв
BR102015029357A2 (pt) The use of bandages and membranes produced with quitosan and combined derivatives with various additives in the regeneration of injured fabrics and healing
Біляєва Comparative Clinical Study of the Wound Healing Effects of a Novel Micropore Particle Technology: Effects on Wounds, Venous Leg Ulcers, and Diabetic Foot Ulcers
RU2195291C2 (ru) Способ лечения гнойных ран
Jones Use of hydrogels and iodine in diabetic foot lesions
UA64934A (en) Complex antibacterial sorption preparation benegol for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and wounds and method for its manufacture
WO2012108851A1 (ru) Композиция для лечения гнойных ран
UA75467C2 (en) Remedy for treating wounds
UA113250U (xx) Комплексний антимікробний сорбційний препарат орнісератосил для профілактики аеробної і анаеробної інфекції та лікування гнійних ран, трофічних виразок, опіків
UA65716A (en) Complex antibacterial sorption composition "benegol forte" for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and burns, method for its manufacture and application
UA75446C2 (en) Composition for topical treatment of pyo-inflammatory processes in soft tissues